Woodline Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-32,932	Closed	-$1.49M	–	170
2020 Q1	$1.49M	Buy	+32,932	New	+$1.49M	0.11%	120